NCT02858297View on ClinicalTrials.gov

Glucosamine as a Novel Adjunctive Therapy in Oral Lichen Planus

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Oral Lichen Planus
Interventions
DRUG

Glucosamine sulfate

Glucosamine (GlcN) is an N-deacetyl amino sugar derived from the complete hydrolysis of chitosan with recently reported immunoregulatory capacity and anti-inflammatory effect

DRUG

triamcinolone acetonide

Topical corticosteroid

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT02858297 - Glucosamine as a Novel Adjunctive Therapy in Oral Lichen Planus | Biotech Hunter | Biotech Hunter